Psych Capital acquires Shortwave Pharma to expand eating disorder treatment portfolio
LONDON, UK: Psych Capital PLC, a leading global investment firm specializing in the healthcare sector, has announced that it has acquired 100% of the issued share capital of Shortwave Pharma Inc., a biopharmaceutical drug-development company. The acquisition will expand Psych…